scispace - formally typeset
G

Gerd Sutter

Researcher at Technische Universität München

Publications -  13
Citations -  639

Gerd Sutter is an academic researcher from Technische Universität München. The author has contributed to research in topics: Vaccinia & Virus. The author has an hindex of 12, co-authored 13 publications receiving 617 citations. Previous affiliations of Gerd Sutter include Paul Ehrlich Institute.

Papers
More filters
Journal ArticleDOI

Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara.

TL;DR: Deletion of the viral IL1betaR gene may be considered a relevant approach to amplify the virus-specific CD8+ memory T-cell response and duration of protective immunity obtained after MVA vaccination.
Book ChapterDOI

Construction and Isolation of Recombinant MVA

TL;DR: This chapter provides state-of-the-art protocols for generation, plaque isolation, molecular characterization, as well as amplification and purification of MVA vector viruses to obtain recombinant viruses for further evaluation.
Journal ArticleDOI

Transient host range selection for genetic engineering of modified vaccinia virus Ankara.

TL;DR: This work reports on easily obtaining recombinant MVA using stringent growth selection on rabbit kidney RK-13 cells and describes the construction and use of new MVA vector plasmids that carry an expression cassette of the vaccinia virus host range gene, K1L, as a transient selectable marker.
Journal ArticleDOI

Rescue of measles virus using a replication-deficient vaccinia-T7 vector

TL;DR: A system which allows the reconstitution of measles virus (MV) from cloned cDNA is described and is especially suitable for studying the functions of N, P and L.
Journal ArticleDOI

Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen

TL;DR: Strong cellular immune responses and reduction of challenge virus burden were demonstrated in animals immunized i.m. and i.r.o. only following homologous intravenous simian-human immunodeficiency virus (SHIV) challenge, and the breadth and magnitude of the induced immune responses correlated with protective efficacy.